These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 8697971

  • 1. [Mechanism of resistance to mitomycin C in a human bladder cancer cell line].
    Xu B, Sun Y, Singh SV.
    Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):343-6. PubMed ID: 8697971
    [Abstract] [Full Text] [Related]

  • 2. Characterization of a human bladder cancer cell line selected for resistance to BMY 25067, a novel analogue of mitomycin C.
    Singh SV, Xu BH, Gupta V, Emerson EO, Zaren HA, Jani JP.
    Cancer Lett; 1995 Aug 16; 95(1-2):49-56. PubMed ID: 7656243
    [Abstract] [Full Text] [Related]

  • 3. Mechanism of differential sensitivity of human bladder cancer cells to mitomycin C and its analogue.
    Xu BH, Gupta V, Singh SV.
    Br J Cancer; 1994 Feb 16; 69(2):242-6. PubMed ID: 8297721
    [Abstract] [Full Text] [Related]

  • 4. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
    Xu BH, Gupta V, Singh SV.
    Arch Biochem Biophys; 1994 Jan 16; 308(1):164-70. PubMed ID: 8311448
    [Abstract] [Full Text] [Related]

  • 5. [DT-diaphorase].
    Mikami K, Shirakusa T, Tsuruo T.
    Gan To Kagaku Ryoho; 1997 Sep 16; 24(11):1606-10. PubMed ID: 9309161
    [Abstract] [Full Text] [Related]

  • 6. The importance of DT-diaphorase in mitomycin C resistance in human colon cancer cell lines.
    Lambert PA, Kang Y, Greaves B, Perry RR.
    J Surg Res; 1998 Dec 16; 80(2):177-81. PubMed ID: 9878310
    [Abstract] [Full Text] [Related]

  • 7. Expression of DT-diaphorase and cytochrome P450 reductase correlates with mitomycin C activity in human bladder tumors.
    Gan Y, Mo Y, Kalns JE, Lu J, Danenberg K, Danenberg P, Wientjes MG, Au JL.
    Clin Cancer Res; 2001 May 16; 7(5):1313-9. PubMed ID: 11350900
    [Abstract] [Full Text] [Related]

  • 8. Biochemical characterization of a mitomycin C-resistant human bladder cancer cell line.
    Singh SV, Scalamogna D, Xia H, O'Toole S, Roy D, Emerson EO, Gupta V, Zaren HA.
    Int J Cancer; 1996 Mar 15; 65(6):852-7. PubMed ID: 8631603
    [Abstract] [Full Text] [Related]

  • 9. Enzymatic and pH modulation of mitomycin C-induced DNA damage in mitomycin C-resistant HCT 116 human colon cancer cells.
    Pan SS, Yu F, Hipsher C.
    Mol Pharmacol; 1993 Jun 15; 43(6):870-7. PubMed ID: 8316219
    [Abstract] [Full Text] [Related]

  • 10. Characterization of a human bladder cancer cell line selected for resistance to mitomycin C.
    Xu BH, Gupta V, Singh SV.
    Int J Cancer; 1994 Sep 01; 58(5):686-92. PubMed ID: 8077054
    [Abstract] [Full Text] [Related]

  • 11. DT-diaphorase as a critical determinant of sensitivity to mitomycin C in human colon and gastric carcinoma cell lines.
    Mikami K, Naito M, Tomida A, Yamada M, Sirakusa T, Tsuruo T.
    Cancer Res; 1996 Jun 15; 56(12):2823-6. PubMed ID: 8665520
    [Abstract] [Full Text] [Related]

  • 12. Characterization of a set of Chinese hamster ovary variant cell lines demonstrating differing sensitivity to mitomycin C.
    Kuehl BL, Buchwald M, Rauth AM.
    Oncol Res; 1993 Jun 15; 5(6-7):213-21. PubMed ID: 8123941
    [Abstract] [Full Text] [Related]

  • 13. Mitomycin C resistance induced by TCF-3 overexpression in gastric cancer cell line MKN28 is associated with DT-diaphorase down-regulation.
    Sagara N, Katoh M.
    Cancer Res; 2000 Nov 01; 60(21):5959-62. PubMed ID: 11085512
    [Abstract] [Full Text] [Related]

  • 14. Lack of a role of glutathione in cellular nonenzymatic activation of BMS-181174, a novel analogue of mitomycin C.
    Xia H, Pinto T, Hu X, Benson PJ, Zaren HA, Gupta V, Singh S.
    Cancer Res; 1996 Aug 01; 56(15):3495-8. PubMed ID: 8758917
    [Abstract] [Full Text] [Related]

  • 15. Tumor-specific synergistic therapy of mitomycin C: modulation of bioreductive activation.
    Sakamoto N, Toge T, Nishiyama M.
    Hiroshima J Med Sci; 1997 Jun 01; 46(2):67-73. PubMed ID: 9232934
    [Abstract] [Full Text] [Related]

  • 16. Reversal of mitomycin C resistance by overexpression of bioreductive enzymes in Chinese hamster ovary cells.
    Baumann RP, Hodnick WF, Seow HA, Belcourt MF, Rockwell S, Sherman DH, Sartorelli AC.
    Cancer Res; 2001 Nov 01; 61(21):7770-6. PubMed ID: 11691791
    [Abstract] [Full Text] [Related]

  • 17. [Mitomycin C and its bioreduction: relevance of NAD(P)H: quinone oxidoreductase activity to mitomycin C-induced DNA damage and cytotoxicity].
    Nishiyama M, Saeki S, Aogi K, Hirabayashi N, Toge T.
    Gan To Kagaku Ryoho; 1993 Jun 01; 20(8):1037-41. PubMed ID: 7685584
    [Abstract] [Full Text] [Related]

  • 18. Characterization of a BMS-181174-resistant human bladder cancer cell line.
    Xia H, Bleicher RJ, Hu X, Srivastava SK, Gupta V, Zaren HA, Singh SV.
    Br J Cancer; 1997 Jun 01; 76(4):461-6. PubMed ID: 9275022
    [Abstract] [Full Text] [Related]

  • 19. DT-diaphorase as a target enzyme for biochemical modulation of mitomycin C.
    Saeki S, Nishiyama M, Toge T.
    Hiroshima J Med Sci; 1995 Sep 01; 44(3):55-63. PubMed ID: 8567314
    [Abstract] [Full Text] [Related]

  • 20. Enhanced cytotoxicity of mitomycin C in human tumour cells with inducers of DT-diaphorase.
    Wang X, Doherty GP, Leith MK, Curphey TJ, Begleiter A.
    Br J Cancer; 1999 Jun 01; 80(8):1223-30. PubMed ID: 10376975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.